<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Article Tag Suite 1.1//EN"
  "https://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink"
         xmlns:mml="http://www.w3.org/1998/Math/MathML"
         article-type="research-article"
         xml:lang="en">
  <front>
    <journal-meta>
      <journal-title-group>
        <journal-title>American Journal of PharmTech Research</journal-title>
        <abbrev-journal-title abbrev-type="publisher">AJPTR</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="epub">2249-3387</issn>
      <publisher>
        <publisher-name>undefined</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">AJPTR64010</article-id>
      <title-group>
        <article-title>A Review on Significance of Risk Assessment In Cardiovascular Diseases</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Prakash</surname>
            <given-names>D.Syam</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lavanya</surname>
            <given-names>V.Leela</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tulasi</surname>
            <given-names>P.SAI</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>V.Satyanarayana</surname>
            <given-names>V.Satyanarayana</given-names>
          </name>
          <xref ref-type="aff" rid="aff1"/>
        </contrib>
      </contrib-group>
      <aff id="aff1">Department of Pharmacy Practice, Narasaraopeta Institute of Pharmaceutical Sciences, Narasaraopet, Guntur (Dt), Andhra Pradesh, India-522601.</aff>
      <pub-date pub-type="epub" iso-8601-date="2016-08-01">
        <month>08</month>
        <day>01</day>
        <year>2016</year>
      </pub-date>
      <volume>6</volume>
      <issue>4</issue>
      <abstract>
        <p>Cardiovascular diseases(CVD) account for nearly one third of all deaths world wide. Consequently the prevention of risk factors for CVD is public health priority in recent times. The available rehabilitation and preventive measures include lifestyle  modification, treatment with drug and intervention procedures. The appropriate application of risk assessment should result in a better quality of life for people with cardiovascular diseases and improve cost effectiveness of healthcare. The success of these measures depends laregely on the skills of patients in the daily management of their condition. The present study reveals that risk assessment can answer many questions in best therapeutic outcomes.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <kwd>Cardiovascular disease</kwd>
        <kwd>Risk assessment</kwd>
        <kwd>Therapeutic outcome</kwd>
        <kwd>Quality of life</kwd>
        <kwd>Cost effectiveness</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <!-- Full article body not available in metadata-only JATS export. See PDF/HTML galley. -->
  </body>
  <back/>
</article>
